Lexaria Bioscience Buy Hold or Sell Recommendation

LXRP -- USA Stock  

USD 0.79  0.0387  4.69%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Lexaria Bioscience Corp is 'Strong Sell'. Macroaxis provides Lexaria Bioscience buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LXRP positions. The advice algorithm takes into account all of Lexaria Bioscience Corp available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from LXRP buy-and-hold prospective. Please see also Lexaria Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell Lexaria BioscienceBuy Lexaria Bioscience
Strong Sell


Hype Condition

Current Valuation

Odds of Distress

Analyst Consensus

Not Available
For the selected time horizon Lexaria Bioscience Corp has a mean deviation of 2.54, semi deviation of 0.0, standard deviation of 3.18, variance of 10.09, downside variance of 0.0 and semi variance of 0.0
We provide buy, hold, or sell recommendation to complement the last-minute expert consensus on Lexaria Bioscience Corp. Our dynamic recommendation engine harnesses multi - dimensional algorithm to analyze the entity potential to grow using all technical and fundamental data available at the time. To make sure Lexaria Bioscience Corp is not overpriced, please verify all Lexaria Bioscience Corp fundamentals including its Gross Profit, Current Ratio as well as the relationship between Current Ratio and Market Capitalization . As Lexaria Bioscience Corp appears to be a penny stock we also strongly suggest to check its Price to Book numbers.

Lexaria Bioscience Trading Alerts and Improvement Suggestions

Lexaria Bioscience generates negative expected return over the last 30 days
Lexaria Bioscience has some characteristics of a very speculative penny stock
Lexaria Bioscience has high historical volatility and very poor performance
Lexaria Bioscience has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 274.25K. Net Loss for the year was (6.49M) with profit before overhead, payroll, taxes, and interest of 395.14K.
LEXARIA CORP currently holds about 3.16M in cash with (2.56M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Roughly 20.0% of the company outstanding shares are owned by corporate insiders

Lexaria Bioscience current analysts recommendations

Target Median Price2.35
Target Mean Price2.35
Recommendation Mean2.00
Target High Price2.35
Number Of Analyst Opinions1
Target Low Price2.35

Lexaria Bioscience Returns Distribution Density

Mean Return0.33Value At Risk4.69
Potential Upside5.88Standard Deviation3.18
 Return Density 

Institutional Investors

Security TypeSharesValue
Sonora Investment Management LlcCommon Shares2 K2 K
Hilton Capital Management LlcCommon Shares150 K140 K
Sonora Investment Management LlcCommon Shares2 K2 K
Hilton Capital Management LlcCommon Shares150 K287 K
Sonora Investment Management LlcCommon Shares2 K4 K
Hilton Capital Management LlcCommon Shares150 K302 K
Sonora Investment Management LlcCommon Shares2 K4 K

Lexaria Bioscience Greeks

Alpha over DOW
Beta against DOW=0.04
Overall volatility
Information ratio =0.15

Lexaria Bioscience Volatility Alert

Lexaria Bioscience Corp exhibits very low volatility with skewness of 0.44 and kurtosis of -0.45. However, we advise investors to further study Lexaria Bioscience Corp technical indicators to make sure all market info is available and is reliable. Lexaria Bioscience Corp is a potential penny stock. Although Lexaria Bioscience may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial stock hype. Please make sure you totally understand upside potential and downside risk of investing in Lexaria Bioscience Corp. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
 Better Than Average     
 Worse Than Average Compare Lexaria Bioscience to competition

Lexaria Bioscience Fundamental Vs Peers

FundamentalsLexaria BiosciencePeer Average
Return On Equity(198.81)% (0.31)%
Return On Asset(114.15)% (0.14)%
Current Valuation66.36M16.62B
Shares Outstanding78.39M571.82M
Shares Owned by Insiders19.98% 10.09%
Shares Owned by Institutions2.11% 39.21%
Price to Earning(13.00)X28.72X
Price to Book23.98X9.51X
Price to Sales250.82X11.42X
Gross Profit395.14K27.38B
Net Income(6.49M)570.98M
Cash and Equivalents3.16M2.7B
Cash per Share0.04X5.01X
Debt to Equity1.40% 48.70%
Current Ratio7.28X2.16X
Book Value Per Share0.04X1.93K
Cash Flow from Operations(2.56M)971.22M
Earnings Per Share(0.09)X3.12X
Number of Employees818.84K
Market Capitalization68.79M19.03B
Total Asset331K29.47B
Retained Earnings(10.99M)9.33B
Working Capital(53K)1.48B
Current Asset279K9.34B
Current Liabilities332K7.9B
   Lexaria Bioscience exotic insider transaction detected [view details]
Search macroaxis.com